Patents Assigned to INNOCOLL PHARMACEUTICALS LIMITED
-
Patent number: 11746141Abstract: The present invention relates to a modified collagen obtainable by providing isolated collagen; freezing the isolated collagen; dehydrating the frozen collagen; and maturing the dehydrated collagen. Also disclosed are methods of preparing the modified collagen and uses thereof.Type: GrantFiled: August 9, 2019Date of Patent: September 5, 2023Assignee: INNOCOLL PHARMACEUTICALS LIMITEDInventors: Alexandra Dietrich, Michael Myers
-
Patent number: 11623947Abstract: There is a need to provide a collagen powder having desirable product characteristics, such as high fluid absorption capacity, while also having processing characteristics that allow commercial manufacturing and handling of the collagen powder. The present invention relates to a collagen powder, a method of manufacture thereof, and uses thereof. In particular, the present invention relates to a process for preparing a collagen powder, the process comprising the steps of providing a collagen source; adjusting the concentration of the collagen source; adjusting the pH of the collagen source; freezing the collagen source; dehydrating the frozen collagen; and degrading the dehydrated collagen to a powder.Type: GrantFiled: April 8, 2013Date of Patent: April 11, 2023Assignee: Innocoll Pharmaceuticals LimitedInventors: Alexandra Dietrich, Michael Myers, Stefan Schneid
-
Publication number: 20220281953Abstract: There is a need to provide a collagen powder having desirable product characteristics, such as high fluid absorption capacity, while also having processing characteristics that allow commercial manufacturing and handling of the collagen powder. The present invention relates to a collagen powder, a method of manufacture thereof, and uses thereof. In particular, the present invention relates to a process for preparing a collagen powder, the process comprising the steps of providing a collagen source; adjusting the concentration of the collagen source; adjusting the pH of the collagen source; freezing the collagen source; dehydrating the frozen collagen; and degrading the dehydrated collagen to a powder.Type: ApplicationFiled: October 18, 2021Publication date: September 8, 2022Applicant: INNOCOLL PHARMACEUTICALS LIMITEDInventors: Alexandra DIETRICH, Michael Myers, Stefan Schneid
-
Publication number: 20220213173Abstract: The present invention relates to a modified collagen obtainable by providing isolated collagen; freezing the isolated collagen; dehydrating the frozen collagen; and maturing the dehydrated collagen. Also disclosed are methods of preparing the modified collagen and uses thereof.Type: ApplicationFiled: March 21, 2022Publication date: July 7, 2022Applicant: INNOCOLL PHARMACEUTICALS LIMITEDInventors: Alexandra DIETRICH, Michael Myers
-
Publication number: 20190359689Abstract: The present invention relates to a modified collagen obtainable by providing isolated collagen; freezing the isolated collagen; dehydrating the frozen collagen; and maturing the dehydrated collagen. Also disclosed are methods of preparing the modified collagen and uses thereof.Type: ApplicationFiled: August 9, 2019Publication date: November 28, 2019Applicant: INNOCOLL PHARMACEUTICALS LIMITEDInventors: Alexandra DIETRICH, Michael Myers
-
Patent number: 10487134Abstract: The present invention relates to a modified collagen obtainable by providing isolated collagen; freezing the isolated collagen; dehydrating the frozen collagen; and maturing the dehydrated collagen. Also disclosed are methods of preparing the modified collagen and uses thereof.Type: GrantFiled: January 9, 2013Date of Patent: November 26, 2019Assignee: INNOCOLL PHARMACEUTICALS LIMITEDInventors: Alexandra Dietrich, Michael Myers
-
Patent number: RE47826Abstract: The invention relates to a drug delivery device for providing local analgesia, local anesthesia or nerve blockade at a site in a human or animal in need thereof, the device comprising a fibrillar collagen matrix; and at least one drug substance selected from the group consisting of amino amide anesthetics, amino ester anesthetics and mixtures thereof, the at least one drug substance being substantially homogeneously dispersed in the collagen matrix, and the at least one drug substance being present in an amount sufficient to provide a duration of local analgesia, local anesthesia or nerve blockade which lasts for at least about one day after administration.Type: GrantFiled: March 17, 2015Date of Patent: January 28, 2020Assignee: INNOCOLL PHARMACEUTICALS LIMITEDInventors: Michael Myers, Philip Wallace Reginald